• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大肠杆菌从头生物合成 2'-岩藻糖基乳糖的代谢工程。

Metabolic Engineering of De Novo Pathway for the Production of 2'-Fucosyllactose in Escherichia coli.

机构信息

State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi, 214122, Jiangsu, China.

International Joint Laboratory on Food Safety, Jiangnan University, Wuxi, 214122, Jiangsu, China.

出版信息

Mol Biotechnol. 2023 Sep;65(9):1485-1497. doi: 10.1007/s12033-023-00657-7. Epub 2023 Jan 18.

DOI:10.1007/s12033-023-00657-7
PMID:36652181
Abstract

2'-Fucosyllactose (2'-FL), one of the most abundant oligosaccharides in human milk, has gained increased attention owing to its nutraceutical and pharmaceutical potential. However, limited availability and high-cost of preparation have limited its widespread application and in-depth investigation of its potential functions. Here, a modular pathway engineering was implemented to construct an Escherichia coli strain to improve the biosynthesis titer of 2'-FL. Before overexpression of manB, manC, gmd, wcaG, and heterologous expression of futC, genes wcaJ and lacZ encoding UDP-glucose lipid carrier transferase and β-galactosidase, respectively, were inactivated from E. coli BL21 (DE3) with the CRISPR-Cas9 system, which inhibited the production of 2'-FL. The results showed that final shake flask culture yielded a 3.8-fold increase in 2'-FL (0.98 g/L) from the engineered strain ELC07. Fed-batch fermentation conditions were optimized in a 3-L bioreactor. The highest titer of 2'-FL (18.22 g/L) was obtained, corresponding to a yield of 0.25 g/g glycerol and a substrate conversion of 0.88 g/g lactose.

摘要

2'-岩藻糖基乳糖(2'-FL)是母乳中最丰富的寡糖之一,由于其具有营养和药用潜力,引起了越来越多的关注。然而,其有限的可用性和高制备成本限制了其广泛应用和对其潜在功能的深入研究。在这里,实施了模块化途径工程,以构建能够提高 2'-FL 生物合成产率的大肠杆菌菌株。在过表达 manB、manC、gmd、wcaG 和异源表达 futC 之前,使用 CRISPR-Cas9 系统敲除了编码 UDP-葡萄糖脂质载体转移酶和β-半乳糖苷酶的基因 wcaJ 和 lacZ,从而抑制了 2'-FL 的产生。结果表明,最终摇瓶培养使工程菌株 ELC07 中的 2'-FL(0.98 g/L)产量增加了 3.8 倍。在 3-L 生物反应器中优化了分批补料发酵条件。获得了最高的 2'-FL 浓度(18.22 g/L),对应的 2'-FL 产率为 0.25 g/g 甘油,底物转化率为 0.88 g/g 乳糖。

相似文献

1
Metabolic Engineering of De Novo Pathway for the Production of 2'-Fucosyllactose in Escherichia coli.大肠杆菌从头生物合成 2'-岩藻糖基乳糖的代谢工程。
Mol Biotechnol. 2023 Sep;65(9):1485-1497. doi: 10.1007/s12033-023-00657-7. Epub 2023 Jan 18.
2
High-Level Biosynthesis of 2'-Fucosyllactose by Metabolically Engineered .通过代谢工程化的. 高效生物合成 2'-岩藻糖基乳糖
J Agric Food Chem. 2022 Jul 27;70(29):9017-9025. doi: 10.1021/acs.jafc.2c02484. Epub 2022 Jul 14.
3
Pathway Optimization of 2'-Fucosyllactose Production in Engineered .工程菌中 2'-岩藻糖基乳糖生产的途径优化。
J Agric Food Chem. 2021 Feb 10;69(5):1567-1577. doi: 10.1021/acs.jafc.0c07224. Epub 2021 Jan 26.
4
Combinatorial metabolic engineering of Escherichia coli for de novo production of 2'-fucosyllactose.大肠杆菌的组合代谢工程化用于从头合成 2'-岩藻糖基乳糖。
Bioresour Technol. 2022 May;351:126949. doi: 10.1016/j.biortech.2022.126949. Epub 2022 Mar 4.
5
Efficient production of 2'-fucosyllactose from fructose through metabolically engineered recombinant Escherichia coli.通过代谢工程重组大肠杆菌从果糖高效生产 2'-岩藻糖基乳糖。
Microb Cell Fact. 2024 Feb 1;23(1):38. doi: 10.1186/s12934-024-02312-5.
6
Metabolic engineering strategies of de novo pathway for enhancing 2'-fucosyllactose synthesis in Escherichia coli.大肠杆菌从头途径代谢工程策略增强 2'-岩藻糖基乳糖的合成。
Microb Biotechnol. 2022 May;15(5):1561-1573. doi: 10.1111/1751-7915.13977. Epub 2021 Nov 29.
7
De novo biosynthesis of 2'-fucosyllactose in a metabolically engineered Escherichia coli using a novel ɑ1,2-fucosyltransferase from Azospirillum lipoferum.利用来自产脂固氮螺菌的一种新型α1,2-岩藻糖基转移酶,在代谢工程改造的大肠杆菌中从头生物合成2'-岩藻糖基乳糖。
Bioresour Technol. 2023 Apr;374:128818. doi: 10.1016/j.biortech.2023.128818. Epub 2023 Mar 2.
8
Engineered Bacillus subtilis for the de novo production of 2'-fucosyllactose.工程枯草芽孢杆菌用于 2'-岩藻糖基乳糖的从头合成。
Microb Cell Fact. 2022 Jun 2;21(1):110. doi: 10.1186/s12934-022-01838-w.
9
Construction of Escherichia coli strains with chromosomally integrated expression cassettes for the synthesis of 2'-fucosyllactose.构建带有染色体整合表达盒的大肠杆菌菌株,用于合成 2'-岩藻糖基乳糖。
Microb Cell Fact. 2013 May 1;12:40. doi: 10.1186/1475-2859-12-40.
10
Glycosyltransferase from Is a Novel α-1,3-Fucosyltransferase that Can Be Used for 3-Fucosyllactose Production In Vivo by Metabolically Engineered .来自 的糖基转移酶是一种新型的 α-1,3-岩藻糖基转移酶,可通过代谢工程化的 用于体内 3-岩藻糖乳糖的生产。
J Agric Food Chem. 2022 Feb 16;70(6):1934-1942. doi: 10.1021/acs.jafc.1c06719. Epub 2022 Jan 6.

引用本文的文献

1
Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability.对健康母亲母乳的非靶向代谢组学分析揭示了代谢物变异的驱动因素。
Sci Rep. 2024 Sep 6;14(1):20827. doi: 10.1038/s41598-024-71677-9.
2
Efficient production of 2'-fucosyllactose from fructose through metabolically engineered recombinant Escherichia coli.通过代谢工程重组大肠杆菌从果糖高效生产 2'-岩藻糖基乳糖。
Microb Cell Fact. 2024 Feb 1;23(1):38. doi: 10.1186/s12934-024-02312-5.

本文引用的文献

1
Metabolic engineering strategies of de novo pathway for enhancing 2'-fucosyllactose synthesis in Escherichia coli.大肠杆菌从头途径代谢工程策略增强 2'-岩藻糖基乳糖的合成。
Microb Biotechnol. 2022 May;15(5):1561-1573. doi: 10.1111/1751-7915.13977. Epub 2021 Nov 29.
2
Pathway Optimization of 2'-Fucosyllactose Production in Engineered .工程菌中 2'-岩藻糖基乳糖生产的途径优化。
J Agric Food Chem. 2021 Feb 10;69(5):1567-1577. doi: 10.1021/acs.jafc.0c07224. Epub 2021 Jan 26.
3
Combinatorial Modular Pathway Engineering for Guanosine 5'-Diphosphate-l-fucose Production in Recombinant .
组合式模块化途径工程在重组.中生产鸟苷 5'-二磷酸-L-岩藻糖
J Agric Food Chem. 2020 May 20;68(20):5668-5675. doi: 10.1021/acs.jafc.0c01064. Epub 2020 May 6.
4
Metabolic engineering of Escherichia coli BL21 (DE3) for de novo production of L-DOPA from D-glucose.大肠杆菌 BL21(DE3)的代谢工程改造用于从头合成 L-DOPA 从 D-葡萄糖。
Microb Cell Fact. 2019 Apr 25;18(1):74. doi: 10.1186/s12934-019-1122-0.
5
Enzymatic and cell factory approaches to the production of human milk oligosaccharides.酶法和细胞工厂方法生产人乳寡糖。
Biotechnol Adv. 2019 Sep-Oct;37(5):667-697. doi: 10.1016/j.biotechadv.2019.03.014. Epub 2019 Mar 29.
6
Activation of colanic acid biosynthesis linked to heterologous expression of the polyhydroxybutyrate pathway in Escherichia coli.聚羟基丁酸途径的异源表达激活了埃希氏菌中 colanic 酸的生物合成。
Int J Biol Macromol. 2019 May 1;128:752-760. doi: 10.1016/j.ijbiomac.2019.02.004. Epub 2019 Feb 3.
7
Human Milk Oligosaccharides: 2'-Fucosyllactose (2'-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula.人乳寡糖:婴儿配方奶粉中的 2'-岩藻糖基乳糖(2'-FL)和乳-N-新四糖(LNnT)。
Nutrients. 2018 Aug 24;10(9):1161. doi: 10.3390/nu10091161.
8
Metabolic engineering of Escherichia coli for producing adipic acid through the reverse adipate-degradation pathway.通过反向己二酸降解途径对大肠杆菌进行代谢工程改造以生产己二酸。
Metab Eng. 2018 May;47:254-262. doi: 10.1016/j.ymben.2018.04.002. Epub 2018 Apr 3.
9
Human milk oligosaccharide consumption by probiotic and human-associated bifidobacteria and lactobacilli.益生菌和人源双歧杆菌及乳杆菌对人乳寡糖的消耗。
J Dairy Sci. 2017 Oct;100(10):7825-7833. doi: 10.3168/jds.2017-12753. Epub 2017 Aug 2.
10
Large scale validation of an efficient CRISPR/Cas-based multi gene editing protocol in Escherichia coli.一种基于CRISPR/Cas的高效多基因编辑方案在大肠杆菌中的大规模验证
Microb Cell Fact. 2017 Apr 24;16(1):68. doi: 10.1186/s12934-017-0681-1.